Reference
- Caligaris-Cappio, F. (1996) "B-chronic lymphocytic leukemia: a malignancy of anti-self B cells", Blood, 87, 2615–2620.
- Kipps, T. (1997) "Chronic lymphocytic leukemia", Curr. Opin. HematoL, 4, 268–276.
- MacLennan, I.C.M. and Gray, D. (1986) "Antigen-driven selection of virgin and memory B cells", ImmunoL Rev., 91, 61–66.
- Salvesen, G.S. and Dixit, V.M. (1997) "Caspases: Intracellular signaling by proteolysis", Cell, 91, 443–446.
- Salvesen, G.S. and Dixit, V.M. (1999) "Caspase activation: the induced-proximity model", Proc. Natl. Acad. Sci. USA, 96, 10964–10967.
- Nishihara, H., Kizaka-Kondoh, S., Inset, P.A. and Ecicmann, L. (2003) "Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2", Proc. Natl. Acad. Sci. USA, 22, 100(15), 8921–8926.
- Gumgumji, A.A., Dawood, T. and Parvez, T. (2003) "Role of COX-2 specific inhibitors in oncogenesis", J. Coll. Physicians Surg. Pak., 13(6), 361–365.
- Davies, G., Salter, J., Hills, M., Martin, L.A., Sacks, N. and Dowsett, M. (2003) "Correlation between cyclooxygenase-2 expres-sion and angiogenesis in human breast cancer", Clin. Cancer Res., 9(7), 2651–2656.
- Sanchez-Alcazar, J.A., Bradbury, D.A., Pang, L. and Knox, A.J. (2003) "Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent path-ways", Lung Cancer, 40(1), 33–44.
- Levitt, R.J. and Pollak, M. (2002) "Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibi-tors on BxPC-3 pancreatic cancer cells", Cancer Res., 62(24), 7372–7376.
- Mizutani, Y., Kamoi, K., Ulcimura, 0., Kawauchi, A. and Mild, T. (2002) "Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer", J. UroL, 168(6), 2650–2654.
- Giles, F.J., Kantarjian, H.M., Bekele, B.N., Cortes, J.E., Faderl, S., Thomas, D.A., et al. (2002) "Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival", Br. J. HaematoL, 119(1), 38–45.
- Jendrossek, V., Handrick, R. and Belka, C. (2003) "Celecoxib activates a novel mitochondrial apoptosis signaling pathway", FASEB J., 17(11), 1547–1549.
- Wiestner, A. and Staudt, L.M. (2003). "Towards molecular diagnosis and targeted therapy of lymphoid malignancies", Semin. HematoL, 40(4), 296–307.
- Chen, L., Widhopf, G., Huynh, L., Rassenti, L., Rai, K.R., Weiss, A. and Kipps, T.J. (2002) "Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leuke-mia", Blood, 100(13), 4609–4614.